Paul David

8PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersHaematological tumoursLiquid biopsiesElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
Post-Surgical Remodeling of Circulating Monocytes Identifies CD86 Expression on Non-Classical Monocytes as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.

|Mar 14, 2026
Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma.

Alara Karabiber, Yong Zhou, Anke Mittelstädt

|Apr 17, 2025
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients.

Isabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie

|Feb 26, 2025
Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.

Paul David, Dina Kouhestani, Frederik J Hansen

|Jun 27, 2024
The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?

Frederik J Hansen, Paul David, Georg F Weber

|Apr 13, 2023
Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease-From Early Cancer Detection to Individualized Cancer Treatment.

Paul David, Anke Mittelstädt, Dina Kouhestani

Pageof 2

Frequent Collaborators

8 joint publications

Georg F Weber

6 joint publications

Frederik Johannes Hansen

5 joint publications

Susanne Merkel

4 joint publications

Anke Mittelstädt